(1)
Leslie, L. A.; Gangan, N.; Tan, H.; Huang, Q.; Yan, J. Clinico-Economic Burden of First-Line Chemoimmunotherapy by Risk Status in Chronic Lymphocytic Leukemia. J Current Med Res Opinion 2022, 5.